Frontlight ResearchEarly access
Ovarian cancer trials in China
185 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleSecondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 400
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05607329 - Phase 2Taking peopleFluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
- Where
- Chongqing
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Chongqing University Cancer Hospital
See details and how to joinNCT05551208 - Phase 3Taking peopleAdjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 590
- Run by
- Fudan University
See details and how to joinNCT04520074 - No phaseNot yet taking people in ChinaIntraperitoneal Lidocaine in Ovarian Cancer Surgery
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Peking University Third Hospital
See details and how to joinNCT05450055 - Phase 2Taking peopleSurgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
- Where
- Guangzhou, Hangzhou, Shanghai
- Age
- 18 years to 75 years
- People
- 167
- Run by
- Shanghai Gynecologic Oncology Group
See details and how to joinNCT03983226 - No phaseTaking peopleRetrospective Study of Brachytherapy
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 300
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT05242861 - No phaseTaking peopleA Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
- Where
- Wuhan
- Age
- 18 years and over
- People
- 490
- Run by
- Tongji Hospital
See details and how to joinNCT05206890 - Phase 2Taking peopleA Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
- Where
- Beijing
- Age
- 18 years and over
- People
- 75
- Run by
- Peking University Third Hospital
See details and how to joinNCT04834544 - No phaseTaking peopleLymphadenectomy in Early Ovarian Cancer
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 656
- Run by
- Sun Yat-sen University
See details and how to joinNCT04710797 - Phase 3Not yet taking people in ChinaStratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)
- Where
- Shanghai
- Age
- 18 years and over
- People
- 410
- Run by
- Shanghai Gynecologic Oncology Group
See details and how to joinNCT04515602